05/14/2026
Encouraging to see all the momentum in RAS/KRAS-targeted research for pancreatic cancer.
Pancreatic cancer patients and families urgently need continued investment in precision oncology, clinical trials, early detection, supportive care, and treatment innovation.
While there is still a long road ahead, advances in targeted therapies represent meaningful progress and growing hope for the future of pancreatic cancer care. ๐